These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 23466098)
21. Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE). Pickens CA; Sordillo LM; Zhang C; Fenton JI Metabolism; 2017 May; 70():177-191. PubMed ID: 28403941 [TBL] [Abstract][Full Text] [Related]
22. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation. Fleming I Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757 [TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. Deng Y; Theken KN; Lee CR J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972 [TBL] [Abstract][Full Text] [Related]
24. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs. Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225 [TBL] [Abstract][Full Text] [Related]
26. Differential contribution of renal cytochrome P450 enzymes to kidney endothelial dysfunction and vascular oxidative stress in obesity. Muñoz M; López-Oliva E; Pinilla E; Rodríguez C; Martínez MP; Contreras C; Gómez A; Benedito S; Sáenz-Medina J; Rivera L; Prieto D Biochem Pharmacol; 2022 Jan; 195():114850. PubMed ID: 34822809 [TBL] [Abstract][Full Text] [Related]
27. Changes in erythrocyte membrane epoxyeicosatrienoic, dihydroxyeicosatrienoic, and hydroxyeicosatetraenoic acids during pregnancy. Somani ST; Zeigler M; Fay EE; Leahy M; Bermudez B; Totah RA; Hebert MF Life Sci; 2021 Jan; 264():118590. PubMed ID: 33069736 [TBL] [Abstract][Full Text] [Related]
28. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration. Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326 [TBL] [Abstract][Full Text] [Related]
29. CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease--the ENCORE Trials. Hermann M; Hellermann JP; Quitzau K; Hoffmann MM; Gasser T; Meinertz T; Münzel T; Fleming I; Lüscher TF Atherosclerosis; 2009 Dec; 207(2):476-9. PubMed ID: 19615687 [TBL] [Abstract][Full Text] [Related]
30. Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients. Duflot T; Laurent C; Soudey A; Fonrose X; Hamzaoui M; Iacob M; Bertrand D; Favre J; Etienne I; Roche C; Coquerel D; Le Besnerais M; Louhichi S; Tarlet T; Li D; Brunel V; Morisseau C; Richard V; Joannidès R; Stanke-Labesque F; Lamoureux F; Guerrot D; Bellien J Sci Rep; 2021 Feb; 11(1):3739. PubMed ID: 33580125 [TBL] [Abstract][Full Text] [Related]
31. The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases. Xu X; Li R; Chen G; Hoopes SL; Zeldin DC; Wang DW Adv Nutr; 2016 Nov; 7(6):1122-1128. PubMed ID: 28140329 [TBL] [Abstract][Full Text] [Related]
32. Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases. Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA PLoS One; 2017; 12(1):e0169584. PubMed ID: 28056085 [TBL] [Abstract][Full Text] [Related]
33. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. Fang X; Weintraub NL; McCaw RB; Hu S; Harmon SD; Rice JB; Hammock BD; Spector AA Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2412-20. PubMed ID: 15284062 [TBL] [Abstract][Full Text] [Related]
35. EET signaling in cancer. Panigrahy D; Greene ER; Pozzi A; Wang DW; Zeldin DC Cancer Metastasis Rev; 2011 Dec; 30(3-4):525-40. PubMed ID: 22009066 [TBL] [Abstract][Full Text] [Related]
36. Cytochrome P450-derived eicosanoids: the neglected pathway in cancer. Panigrahy D; Kaipainen A; Greene ER; Huang S Cancer Metastasis Rev; 2010 Dec; 29(4):723-35. PubMed ID: 20941528 [TBL] [Abstract][Full Text] [Related]
37. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock. Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Manthati VL; Falck JR; Malik KU Nitric Oxide; 2013 Sep; 33():18-41. PubMed ID: 23684565 [TBL] [Abstract][Full Text] [Related]
38. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry. Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834 [TBL] [Abstract][Full Text] [Related]